Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €234.26 EUR
Change Today -1.44 / -0.61%
Volume 9.0
PY2 On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:59 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert W. Duggan

Chairman and Chief Executive Officer, Pharmacyclics Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
70--
As of Fiscal Year 2014

Background*

Mr. Robert W. Duggan, also known as Bob, has been the Chief Executive Officer of Pharmacyclics Inc. since February 12, 2009. Mr. Duggan served as Interim Chief Financial Officer of Pharmacyclics Inc. since October 31, 2008 and Interim Chief Executive Officer from September 2008 to February 2009. Mr. Duggan served as Chief Executive Officer of Computer Motion, Inc. since 1997. He founded Robert W. Duggan & Associates. He served as Secretary at Artificial Life, Inc. He ...

Read Full Background

Corporate Headquarters*

999 East Arques Avenue
Sunnyvale, California 94085

United States

Phone: 408-774-0330
Fax: 408-774-0340

Board Members Memberships*

Former Chairman of the Board of Directors and Chief Executive Officer
2003-2011
Former Director
2007-Present
Chairman and Chief Executive Officer

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PY2:GR €234.26 EUR -1.44

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr11.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMACYCLICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.